Bhanu Prasad Venkatesulu
Overview
Explore the profile of Bhanu Prasad Venkatesulu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
675
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hsieh R, Krishnan S, Wu R, Boda A, Liu A, Winkler M, et al.
Sci Immunol
. 2022 Jun;
7(72):eabl9330.
PMID: 35687697
Radiotherapy (RT) of colorectal cancer (CRC) can prime adaptive immunity against tumor-associated antigen (TAA)-expressing CRC cells systemically. However, abscopal tumor remissions are extremely rare, and the postirradiation immune escape mechanisms...
12.
Giridhar P, Venkatesulu B, Yoo R, V P, Rath G, Mallick S, et al.
Future Sci OA
. 2022 Apr;
8(4):FSO791.
PMID: 35369277
Aim: Salivary duct carcinoma (SDC) is a rare and aggressive malignancy. The optimal treatment protocols are debated. Methodology: A systematic search and individual patient data analysis of published cases of...
13.
Chou B, Venkatesulu B, Coleman R, Harkenrider M, Small Jr W
Int J Gynecol Cancer
. 2022 Mar;
32(3):216-224.
PMID: 35256406
In the modern era, cervical cancer treatment has become more multidisciplinary in nature. Accurate and precise staging based on clinical and radiographic findings, as well as identification of pathologic and...
14.
Venkatesulu B, Chan D, Giridhar P, Upadhyay R, Sharma A, Elghazawy H, et al.
Future Oncol
. 2022 Feb;
18(15):1885-1895.
PMID: 35132868
Pancreatic cancer is a devastating disease with a 5-year survival rate of 5-10%. Radiation is commonly used in neoadjuvant and adjuvant settings to improve local control. Studies have shown that...
15.
Pathy S, Venkatesulu B, Mallick S, Deo S, Mohanti B
Natl Med J India
. 2021 Jul;
33(5):271-275.
PMID: 34213452
Background: . Tumours of the eyelid are a rare subgroup of neoplasms with varied histology and inherent differences in clinical behaviour. Surgery is the standard of care, and adjuvant radiation...
16.
Venkatesulu B, Chandrasekar V, Girdhar P, Advani P, Sharma A, Elumalai T, et al.
JNCI Cancer Spectr
. 2021 Apr;
5(2):pkaa102.
PMID: 33875976
Background: Cancer patients with coronavirus disease 2019 (COVID-19) have been reported to have double the case fatality rate of the general population. Methods: A systematic search of PubMed, Embase, and...
17.
Upadhyay R, Venkatesulu B, Giridhar P, Kim B, Sharma A, Elghazawy H, et al.
Radiother Oncol
. 2021 Feb;
157:225-233.
PMID: 33577865
Background: Despite the modern advances in treatment techniques, the survival of locally advanced lung cancer patients continues to remain poor. Circulating lymphocytes have an important role to play in local...
18.
Elghazawy H, Venkatesulu B, Verma V, Pushparaji B, Monlezun D, Marmagkiolis K, et al.
Crit Rev Oncol Hematol
. 2020 Aug;
153:103006.
PMID: 32777728
Background: Breast cancer patients often receive cardiotoxic drugs such as anthracyclines (ANT) and Trastuzumab. Numerous trials have tested angiotensin converting enzyme inhibitors (ACEi), angiotensin receptor blockers (ARB), and beta-blockers (BB)...
19.
Venkatesulu B, Sanders K, Hsieh C, Kim B, Krishnan S
Cancer Rep (Hoboken)
. 2020 Jul;
2(2):e1152.
PMID: 32721134
Objective: Cancer survivorship has thrown the spotlight on the incidence of nonmalignant chronic diseases in cancer patients. Endothelial injury is increasingly recognized as a consequence of cancer treatment, particularly after...
20.
Elghazawy H, Bakkach J, Zaghloul M, Abusanad A, Hussein M, Alorabi M, et al.
Future Oncol
. 2020 Jul;
16(31):2551-2567.
PMID: 32715776
Breast cancer is the most common malignancy among women worldwide. The current COVID-19 pandemic represents an unprecedented challenge leading to care disruption, which is more severe in low- and middle-income...